These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3117700)

  • 1. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
    Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(4):270-7. PubMed ID: 3117700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K; Roberts MC; Owens L; Fife M; Smith AL
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.
    Bauernfeind A; Rotter K; Weisslein-Pfister C
    Infection; 1987; 15(4):278-80. PubMed ID: 3117701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
    Hoogkamp-Korstanje JA; van der Laag J
    Antonie Van Leeuwenhoek; 1980; 46(1):100-1. PubMed ID: 6772098
    [No Abstract]   [Full Text] [Related]  

  • 6. Postal transport of sputa from cystic fibrosis patients does not decrease the microbiological yield.
    Hoppe JE; Holzwarth I; Stern M
    Zentralbl Bakteriol; 1997 Nov; 286(4):468-71. PubMed ID: 9440195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.
    Kerr J
    J Infect; 1994 May; 28(3):305-10. PubMed ID: 7522262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
    Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
    J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.
    Seale TW; Thirkill H; Tarpay M; Flux M; Rennert OM
    J Clin Microbiol; 1979 Jan; 9(1):72-8. PubMed ID: 107186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Interactions in the Cystic Fibrosis Airway.
    Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiological study of the respiratory tract in children with cystic fibrosis].
    Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.
    Hogardt M; Trebesius K; Geiger AM; Hornef M; Rosenecker J; Heesemann J
    J Clin Microbiol; 2000 Feb; 38(2):818-25. PubMed ID: 10655391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenome - Inferred bacterial replication rates in cystic fibrosis airways.
    Pienkowska K; Wiehlmann L; Tümmler B
    J Cyst Fibros; 2019 Sep; 18(5):653-656. PubMed ID: 30685331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.
    Hammerschlag MR; Harding L; Macone A; Smith AL; Goldmann DA
    J Clin Microbiol; 1980 Jun; 11(6):552-7. PubMed ID: 6776135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation.
    Wahab AA; Janahi IA; Marafia MM; El-Shafie S
    J Trop Pediatr; 2004 Aug; 50(4):229-33. PubMed ID: 15357563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.